Characteristics of IVF patients before treatment: where do we start?

Characteristics of IVF patients before treatment: where do we start?

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Walsh, A, Collins, G, Walsh, D, Sills, E
Μορφή:	Journal article
Έκδοση:	2010

Παρόμοια τεκμήρια

Pre-treatment preferences and characteristics among patients seeking in vitro fertilisation.
ανά: Walsh, A, κ.ά.
Έκδοση: (2009)

Application of EU tissue and cell directive screening protocols to anonymous oocyte donors in western Ukraine: data from an Irish IVF programme.
ανά: Walsh, A, κ.ά.
Έκδοση: (2010)

Bivariate analysis of basal serum anti-Mullerian hormone measurements and human blastocyst development after IVF.
ανά: Sills, E, κ.ά.
Έκδοση: (2011)

Overview of Antifungal Drugs against Paracoccidioidomycosis: How Do We Start, Where Are We, and Where Are We Going?
ανά: Lívia do Carmo Silva, κ.ά.
Έκδοση: (2020-11-01)

A hole revolution, or are we back where we started?
ανά: Pooley, O
Έκδοση: (2006)

Pre-treatment preferences and characteristics among patients seeking in vitro fertilisation
ανά: Walsh David J, κ.ά.
Έκδοση: (2009-12-01)

Bivariate analysis of basal serum anti-Müllerian hormone measurements and human blastocyst development after IVF
ανά: Sills E Scott, κ.ά.
Έκδοση: (2011-12-01)

30 years of Gender Studies - where we started out and where we're headed
ανά: Helena Skálová
Έκδοση: (2022-01-01)

A Five-Decade Text Mining Analysis of Cochlear Implant Research: Where We Started and Where We Are Heading
ανά: Idit Tessler, κ.ά.
Έκδοση: (2023-10-01)

Orchesting Inclusive Evaluation in Schools. Where We Could Start?
ανά: Mª Amparo Calatayud
Έκδοση: (2019-12-01)

Optimisation of thrombolysis treatment: where to start?
ανά: Penaloza, M, κ.ά.
Έκδοση: (2012)

NISQ computing: where are we and where do we go?
ανά: Jonathan Wei Zhong Lau, κ.ά.
Έκδοση: (2022-09-01)

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going
ανά: Omarini C, κ.ά.
Έκδοση: (2018-01-01)

Lacrimal irrigation before intraocular surgery: Where are we today?
ανά: Akshay Gopinathan Nair
Έκδοση: (2024-10-01)

Patient Blood Management: where to start?
ανά: Liana Maria Torres de Araujo Azi, κ.ά.
Έκδοση: (2016-06-01)

Portrait of early science education in majority dual language learner classrooms: Where do we start?
ανά: Brooke Rumper, κ.ά.
Έκδοση: (2021-10-01)

EdTech - Where Do I Start?
ανά: Nancy Caukin
Έκδοση: (2018-10-01)

ColVI myopathies: where do we stand, where do we go?
ανά: Allamand Valérie, κ.ά.
Έκδοση: (2011-09-01)

Treatment Of Diabetes In Bullous Pemphigoid Patients: Where Do We Stand?
ανά: Maria Alexandre, κ.ά.
Έκδοση: (2023-01-01)

Start where you are /
ανά: Gardner, Chris., (Chris P.), κ.ά.
Έκδοση: (2011)

Where it all started
ανά: Long Zhang, κ.ά.
Έκδοση: (2023-04-01)

A descriptive study of oocyte, blood, and organ/tissue donation features among fertility patients in Ireland
ανά: Sills, E, κ.ά.
Έκδοση: (2010)

Where we are, where we are going
ανά: Teresa Bermejo-Vicedo, κ.ά.
Έκδοση: (2020-03-01)

Where we are - where we are heading
ανά: Andreas Schaffner
Έκδοση: (2004-01-01)

What are the Benefits of Diagnosing Endometriosis Before IVF?
ανά: Chii Ruey Tzeng
Έκδοση: (2023-12-01)

Therapeutic options for women with infertility before IVF
ανά: Н. О. Данкович, κ.ά.
Έκδοση: (2017-04-01)

A descriptive study of selected oocyte, blood and organ/tissue donation features among fertility patients in Ireland.
ανά: Sills, E, κ.ά.
Έκδοση: (2010)

Scoping review of brucellosis in Cameroon: Where do we stand, and where are we going?
ανά: Christopher G Laine, κ.ά.
Έκδοση: (2020-01-01)

Survivorship Data in Prostate Cancer: Where Are We and Where Do We Need To Be?
ανά: Beth Russell, κ.ά.
Έκδοση: (2024-01-01)

Expert Systems: Where Are We? And Where Do We Go from Here?
ανά: Davis, κ.ά.
Έκδοση: (2004)

Editorial: Where Are We Now and Where Do We Go From Here
ανά: Gabriele Manganaro
Έκδοση: (2022-01-01)

Balancing selected medication costs with total number of daily injections: a preference analysis of GnRH-agonist and antagonist protocols by IVF patients.
ανά: Sills, E, κ.ά.
Έκδοση: (2012)

CCDs and WET: where are we and where are we going
ανά: O’Donoghue D., κ.ά.
Έκδοση: (2000-09-01)

“We start where we are”: a qualitative study of barriers and pragmatic solutions to the assessment and reporting of implementation strategy fidelity
ανά: Christopher F. Akiba, κ.ά.
Έκδοση: (2022-10-01)

Where are we now and where are we headed?
ανά: Ewan A. Langan
Έκδοση: (2023-06-01)

Botanica. Where are we, and where are we going?
ανά: Zigmantas Gudžinskas
Έκδοση: (2022-06-01)

Treatment and research lines for the patient with COVID-19. What do we have and where are we going?
ανά: Carolina Gotera
Έκδοση: (2020-07-01)

WHO ARE WE, WHAT ARE WE DOING, WHERE ARE WE GOING?
ανά: CHRISTOPHER POLLITT
Έκδοση: (2020-09-01)

Late Sodium Current of the Heart: Where Do We Stand and Where Are We Going?
ανά: Balázs Horváth, κ.ά.
Έκδοση: (2022-02-01)

The Role of Angiogenesis in Haemophilic Arthropathy: Where Do We Stand and Where Are We Going?
ανά: Alexandra Agapidou, κ.ά.
Έκδοση: (2016-05-01)